Pfizer Inc. shares underperform on Tuesday compared to competitors, despite daily gains

Shares of Pfizer Inc. PFE,
+ 0.08%
advanced 0.08% higher to $ 37.31 Tuesday, in what proved to be a rough trading session for the stock market, with the S&P 500 SPX index,
-0.15%
falling 0.15% to 3,849.62 and the Dow Jones Industrial Average DJIA,
-0.07%
falling 0.07% to 30,937.04. This was the third consecutive day of earnings for the stock. Pfizer Inc. closed $ 5.77 short of its 52-week high ($ 43.08), which the company reached on December 9.

The stock showed mixed performance when compared to some of its competitors on Tuesday, such as Johnson & Johnson JNJ,
+ 2.71%
rose 2.71% to $ 170.48, Merck & Co. Inc. MRK,
-1.11%
fell 1.11% to $ 80.25 and Novartis AG ADR NVS,
-2.57%
fell 2.57% to $ 95.94. Turnover (27.5 M) remained 17.4 million below its average 50-day volume of 44.9 M.

Editor’s note: this story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

.Source